Riskpilot← Back to searchSign inGet full accessHyamedix ApS
APSActiveCVR 39177749Nordre Fasanvej 215Manufacture of basic pharmaceutical products · NACE 2110Est. 20172 employeeswww.hyamedix.com
Revenue 2024
DKK -36K
-175% vs 2023
EBITDA margin
4947.0%
+8% vs 2023
Equity ratio
-398.7%
Financial strength
Net profit 2024
DKK -1,4M
+50% vs 2023
| Revenue | DKK -36K | -175% |
| EBITDA | DKK -1,8M | +8% |
| Net profit | DKK -1,4M | +50% |
| Total assets | DKK 2,3M | -49% |
| Equity | DKK -9,2M | -18% |
| Employees | 2 | — |
Legal name
Hyamedix ApS
CVR number
39177749
Legal form
Anpartsselskab
NACE code
2110 · Manufacture of basic pharmaceutical products
Founded
15. december 2017
Share capital
DKK 45.591
Employees
2 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to medlemmer af bestyrelsen i forening eller af et medlem af bestyrelsen i forening med en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at eje teknologier til udlicensiering eller eje kapitalandele i andre virksomheder samt enhver hermed beslægtet virksomhed og drift.
Address
Nordre Fasanvej 215
Phone
+4553520044
Website
www.hyamedix.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 954 | 2.556 | 1.402 | -2.705 | -2.134 | 48 | -36 |
| Staff expenses | -0 | -352 | -1.369 | -1.884 | -2.878 | -2.753 | -1.979 | -1.744 |
| EBITDA | 0 | 1 | 15 | -482 | -5.582 | -4.888 | -1.931 | -1.780 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 0 | 1 | 15 | -482 | -5.582 | -4.888 | -1.931 | -1.780 |
| Net financials | 0 | -1 | -4 | -5 | -243 | -319 | -521 | -694 |
| Profit before tax | 0 | 0 | 11 | -486 | -5.825 | -5.207 | -2.452 | -2.474 |
| Tax | -0 | -0 | 3 | -0 | 149 | -0 | 299 | -1.103 |
| Net profit | 0 | 0 | 8 | -486 | -5.974 | -5.207 | -2.751 | -1.371 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 1 | 1.034 | 1.155 | 2.251 | 3.561 | 1.853 | 4.484 | 2.301 |
| Equity | 1 | 1 | 9 | 1.523 | -3.855 | -5.052 | -7.803 | -9.173 |
| Long-term debt | 0 | 0 | 0 | 0 | 6.117 | 6.417 | 8.436 | 8.778 |
| Short-term debt | 0 | 1.033 | 1.146 | 729 | 1.300 | 489 | 3.851 | 2.696 |
| Total debt | 0 | 1.033 | 1.146 | 729 | 7.417 | 6.906 | 12.287 | 11.474 |
EBITDA margin
-177951800.0%
This company
15.8%
Market median
-1126277315% vs market
20172024
Equity ratio
-398.7%
This company
38.2%
Market median
-1144% vs market
20172024
Return on equity
-137070200.0%
This company
18.4%
Market median
-744946839% vs market
20172024
Net profit margin
-137070200.0%
This company
8.1%
Market median
-1692224791% vs market
20172024
Asset turnover
-0.02×
This company
1.12×
Market median
-102% vs market
20172024
Debt / equity
1.25×
This company
0.62×
Market median
-102% vs market
20172024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-12-15 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KS Management | Management | 2023 | — | — |
HZ Founder | Founder | 2017 | — | — |
BF Management | Management | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2017 | — | — | |
| Deputy Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Vivida ApS | Company | 33.3% | 33.3% | 2017 |
Ginnerup Capital ApS | Company | 15.0% | 15.0% | 2023 |
| Individual | 5.0% | 5.0% | 2023 | |
Jafa Holding ApS | Company | 5.0% | 5.0% | 2023 |
Ginkgo ApS | Company | 5.0% | 5.0% | 2023 |
| Individual | 33.3% | 33.3% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ginnerup Capital ApS
Hyamedix ApS Board members of Hyamedix ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Khadija Schwach-Abdellaoui | Management | 0 companies |
| Huang Zhe | Founder | 0 companies |
| Birgit Fuhlendorff | Management | 0 companies |
| Timothy James Eviston | Board of Directors | 0 companies |
| Michael Foldager Johansen | Chairman | 0 companies |
| Jesper Ahlmann Funding Andersen | Deputy Chairman | 0 companies |